Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 247
7
Diseases
25
Unique genes
0.229
Avg. similarity score
Atrophoderma vermiculata
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Atrophoderma vermiculata
Burnett schwartz berberian syndrome
Tricuspid atresia
Keratosis follicularis spinulosa decalvans
Common migraine
Developmental dysplasia of the hip
pediatric systemic lupus erythematosus
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Atrophoderma vermiculata | 5 | 5 | 1 |
| Burnett schwartz berberian syndrome | 5 | 5 | 1 |
| Tricuspid atresia | 5 | 5 | 1 |
| Keratosis follicularis spinulosa decalvans | 4 | 4 | 3 |
| Common migraine | 3 | 3 | 10 |
| Developmental dysplasia of the hip | 3 | 3 | 14 |
| pediatric systemic lupus erythematosus | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| LRP1 | 6 / 7 | Atrophoderma vermiculata, Burnett schwartz berberian syndrome, Common migraine, Developmental dysplasia of the hip and 2 more |
| SAT1 | 2 / 7 | Keratosis follicularis spinulosa decalvans, pediatric systemic lupus erythematosus |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Degradation of GABA | Reactome | 1 / 2 | 240× | 4.16e-3 | 3.87e-2 ✓ sig. |
| Malaria | KEGG | 2 / 50 | 19.2× | 4.79e-3 | 4.27e-2 ✓ sig. |
| Cholesterol metabolism | KEGG | 2 / 51 | 18.8× | 4.98e-3 | 4.37e-2 ✓ sig. |
| Interconversion of polyamines | Reactome | 1 / 3 | 160× | 6.23e-3 | 5.06e-2 |
| ATF6 (ATF6-alpha) activates chaperones | Reactome | 1 / 4 | 120× | 8.30e-3 | 6.10e-2 |
| CREB3 factors activate genes | Reactome | 1 / 5 | 96.1× | 1.04e-2 | 7.02e-2 |
| Chylomicron clearance | Reactome | 1 / 5 | 96.1× | 1.04e-2 | 7.02e-2 |
| Defective LFNG causes SCDO3 | Reactome | 1 / 5 | 96.1× | 1.04e-2 | 7.02e-2 |
| Tachykinin receptors bind tachykinins | Reactome | 1 / 5 | 96.1× | 1.04e-2 | 7.02e-2 |
| TNFR1-mediated ceramide production | Reactome | 1 / 6 | 80.1× | 1.24e-2 | 7.78e-2 |
| Pre-NOTCH Processing in Golgi | Reactome | 1 / 6 | 80.1× | 1.24e-2 | 7.78e-2 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | Reactome | 1 / 7 | 68.6× | 1.45e-2 | 8.53e-2 |
| TNF signaling | Reactome | 1 / 7 | 68.6× | 1.45e-2 | 8.53e-2 |
| Noncanonical activation of NOTCH3 | Reactome | 1 / 8 | 60.1× | 1.65e-2 | 9.23e-2 |
| Cargo recognition for clathrin-mediated endocytosis | Reactome | 2 / 106 | 9.1× | 2.03e-2 | 1.04e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of lysosomal protein catabolic process | GO:1905167 | 2 / 5 | 299× | 1.71e-5 | 7.95e-4 ✓ sig. |
| defense response to Gram-positive bacterium | GO:0050830 | 4 / 135 | 22.1× | 2.93e-5 | 1.20e-3 ✓ sig. |
| positive regulation of action potential | GO:0045760 | 2 / 7 | 214× | 3.59e-5 | 1.40e-3 ✓ sig. |
| negative regulation of macromolecule metabolic process | GO:0010605 | 2 / 7 | 214× | 3.59e-5 | 1.40e-3 ✓ sig. |
| amyloid-beta clearance by cellular catabolic process | GO:0150094 | 2 / 8 | 187× | 4.79e-5 | 1.74e-3 ✓ sig. |
| negative regulation of heart rate | GO:0010459 | 2 / 12 | 125× | 1.12e-4 | 3.30e-3 ✓ sig. |
| antifungal humoral response | GO:0019732 | 2 / 13 | 115× | 1.33e-4 | 3.74e-3 ✓ sig. |
| response to yeast | GO:0001878 | 2 / 16 | 93.4× | 2.04e-4 | 5.11e-3 ✓ sig. |
| amyloid-beta clearance | GO:0097242 | 2 / 17 | 87.9× | 2.31e-4 | 5.58e-3 ✓ sig. |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 2 / 18 | 83.1× | 2.59e-4 | 6.07e-3 ✓ sig. |
| regulation of protein metabolic process | GO:0051246 | 2 / 24 | 62.3× | 4.66e-4 | 9.12e-3 ✓ sig. |
| lysosomal transport | GO:0007041 | 2 / 26 | 57.5× | 5.48e-4 | 1.01e-2 ✓ sig. |
| antimicrobial humoral immune response mediated by antimicrobial peptide | GO:0061844 | 3 / 124 | 18.1× | 5.90e-4 | 1.07e-2 ✓ sig. |
| artery morphogenesis | GO:0048844 | 2 / 27 | 55.4× | 5.91e-4 | 1.07e-2 ✓ sig. |
| negative regulation of blood pressure | GO:0045776 | 2 / 28 | 53.4× | 6.36e-4 | 1.13e-2 ✓ sig. |